Our CardiologistsMeet the specialists who make up Ascot Cardiology Group

Welcome To Ascot Cardiology Group

Ascot Cardiology Group is a private, Auckland-based Cardiology Group dedicated to providing excellence in the diagnosis and treatment of heart problems and conditions. Situated in the Ascot Hospital in Auckland’s Greenlane, Ascot Cardiology Group is made up of a highly experienced team of both interventional and non-interventional heart specialists.

We provide a large range of specialised heart-related diagnostics procedures ranging from resting ECG tests, stress echo tests to echocardiograms, cardioversion and coronary angiograms. Additional procedures that we carry out under referral include coronary angioplasty, coronary artery bypass surgery and pacemaker insertion. Please see our cardiology services list for a full list of our cardiology and heart diagnostic procedures.

Ascot Cardiology Group provide the highest quality patient care and offer great support services. If you’d like to enquire further about our services or if you are a doctor and would like to refer a patient for heart tests, please feel free to contact us directly or use our online GP referrals form.

Ascot Cardiology Group is an Affiliated Provider of services to Southern Cross Insurance and can arrange your cover directly with Southern Cross, once your cardiologist has determined what tests or procedures are required. If you have health cover with an alternative health insurance provider, we can also advise you on how to organise your prior approval.

 

Latest News
Novel Oral Anticoagulants in Atrial Fibrillation

Prepared by Dr Hitesh Patel. Anticoagulation in patients with AF reduces stroke and mortality compared to placebo. NOACs reduce mortality compared with warfarin. In our GP symposium of 2012, we discussed the potential role of dabigatran (Pradaxa) instead of warfarin in those with atrial fibrillation (AF). Given the importance of this topic, we discussed this subject […]

Read Article

Latest News

Novel Oral Anticoagulants in Atrial Fibrillation

Prepared by Dr Hitesh Patel. Anticoagulation in patients with AF reduces stroke and mortality compared to placebo. NOACs reduce mortality compared with warfarin. In our GP symposium of 2012, we discussed the potential role of dabigatran (Pradaxa) instead of warfarin in those with atrial fibrillation (AF). Given the importance of this topic, we discussed this subject […]